Additional Metadata
Keywords Administration, Oral, Cardiovascular Diseases/*drug therapy, Clinical Trials, Humans, Platelet Aggregation Inhibitors/pharmacology/*therapeutic use, Platelet Glycoprotein GPIIb-IIIa Complex/*antagonists & inhibitors, Research Support, Non-U.S. Gov't
Persistent URL dx.doi.org/10.1053/euhj.2001.2751, hdl.handle.net/1765/13020
Journal European Heart Journal
Citation
Leebeek, F.W.G, Boersma, H, Cannon, C.P, Simoons, M.L, & van de Werf, F.J.J. (2002). Oral glycoprotein IIb/IIIa receptor inhibitors in patients with cardiovascular disease: why were the results so unfavourable.. European Heart Journal (Vol. 23, pp. 444–457). doi:10.1053/euhj.2001.2751